120 related articles for article (PubMed ID: 27262406)
1. From tamoxifen to dendrogenin A: The discovery of a mammalian tumor suppressor and cholesterol metabolite.
Silvente-Poirot S; de Medina P; Record M; Poirot M
Biochimie; 2016 Nov; 130():109-114. PubMed ID: 27262406
[TBL] [Abstract][Full Text] [Related]
2. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells.
Segala G; de Medina P; Iuliano L; Zerbinati C; Paillasse MR; Noguer E; Dalenc F; Payré B; Jordan VC; Record M; Silvente-Poirot S; Poirot M
Biochem Pharmacol; 2013 Jul; 86(1):175-89. PubMed ID: 23500540
[TBL] [Abstract][Full Text] [Related]
3. Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties.
Dalenc F; Poirot M; Silvente-Poirot S
Curr Med Chem; 2015; 22(30):3533-49. PubMed ID: 26179999
[TBL] [Abstract][Full Text] [Related]
4. The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers.
Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2018 Jul; 153():75-81. PubMed ID: 29409832
[TBL] [Abstract][Full Text] [Related]
5. When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite.
Poirot M; Silvente-Poirot S
Biochem Soc Trans; 2016 Apr; 44(2):631-7. PubMed ID: 27068981
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol epoxide hydrolase and cancer.
Silvente-Poirot S; Poirot M
Curr Opin Pharmacol; 2012 Dec; 12(6):696-703. PubMed ID: 22917620
[TBL] [Abstract][Full Text] [Related]
7. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands.
de Medina P; Paillasse MR; Segala G; Poirot M; Silvente-Poirot S
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13520-5. PubMed ID: 20615952
[TBL] [Abstract][Full Text] [Related]
8. Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties.
de Medina P; Paillasse MR; Segala G; Voisin M; Mhamdi L; Dalenc F; Lacroix-Triki M; Filleron T; Pont F; Saati TA; Morisseau C; Hammock BD; Silvente-Poirot S; Poirot M
Nat Commun; 2013; 4():1840. PubMed ID: 23673625
[TBL] [Abstract][Full Text] [Related]
9. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
[TBL] [Abstract][Full Text] [Related]
10. Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands.
de Medina P; Paillasse MR; Ségala G; Khallouki F; Brillouet S; Dalenc F; Courbon F; Record M; Poirot M; Silvente-Poirot S
Chem Phys Lipids; 2011 Sep; 164(6):432-7. PubMed ID: 21641337
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the microsomal tamoxifen binding site.
Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
[TBL] [Abstract][Full Text] [Related]
12. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor.
Voisin M; de Medina P; Mallinger A; Dalenc F; Huc-Claustre E; Leignadier J; Serhan N; Soules R; Ségala G; Mougel A; Noguer E; Mhamdi L; Bacquié E; Iuliano L; Zerbinati C; Lacroix-Triki M; Chaltiel L; Filleron T; Cavaillès V; Al Saati T; Rochaix P; Duprez-Paumier R; Franchet C; Ligat L; Lopez F; Record M; Poirot M; Silvente-Poirot S
Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9346-E9355. PubMed ID: 29078321
[TBL] [Abstract][Full Text] [Related]
13. The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.
Bauriaud-Mallet M; Vija-Racaru L; Brillouet S; Mallinger A; de Medina P; Rives A; Payre B; Poirot M; Courbon F; Silvente-Poirot S
J Steroid Biochem Mol Biol; 2019 Sep; 192():105390. PubMed ID: 31170473
[TBL] [Abstract][Full Text] [Related]
14. A fast UPLC-HILIC method for an accurate quantification of dendrogenin A in human tissues.
Soulès R; Audouard-Combe F; Huc-Claustre E; de Medina P; Rives A; Chatelut E; Dalenc F; Franchet C; Silvente-Poirot S; Poirot M; Allal B
J Steroid Biochem Mol Biol; 2019 Nov; 194():105447. PubMed ID: 31415823
[TBL] [Abstract][Full Text] [Related]
15. Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite.
Poirot M; Soules R; Mallinger A; Dalenc F; Silvente-Poirot S
Biochimie; 2018 Oct; 153():139-149. PubMed ID: 29654865
[TBL] [Abstract][Full Text] [Related]
16. The Cholesterol-5,6-Epoxide Hydrolase: A Metabolic Checkpoint in Several Diseases.
de Medina P; Ayadi S; Diallo K; Buñay J; Pucheu L; Soulès R; Record M; Brillouet S; Vija L; Courbon F; Silvente-Poirot S; Poirot M
Adv Exp Med Biol; 2024; 1440():149-161. PubMed ID: 38036879
[TBL] [Abstract][Full Text] [Related]
17. Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.
Payré B; de Medina P; Boubekeur N; Mhamdi L; Bertrand-Michel J; Tercé F; Fourquaux I; Goudounèche D; Record M; Poirot M; Silvente-Poirot S
Mol Cancer Ther; 2008 Dec; 7(12):3707-18. PubMed ID: 19074846
[TBL] [Abstract][Full Text] [Related]
18. Surprising unreactivity of cholesterol-5,6-epoxides towards nucleophiles.
Paillasse MR; Saffon N; Gornitzka H; Silvente-Poirot S; Poirot M; de Medina P
J Lipid Res; 2012 Apr; 53(4):718-25. PubMed ID: 22285872
[TBL] [Abstract][Full Text] [Related]
19. Improvement of 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestane-3β,5α,6β-triol and 6-oxo-cholestan-3β,5α-diol recovery for quantification by GC/MS.
Soules R; Noguer E; Iuliano L; Zerbinati C; Leignadier J; Rives A; de Medina P; Silvente-Poirot S; Poirot M
Chem Phys Lipids; 2017 Oct; 207(Pt B):92-98. PubMed ID: 28554594
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol-5,6-epoxides: chemistry, biochemistry, metabolic fate and cancer.
Poirot M; Silvente-Poirot S
Biochimie; 2013 Mar; 95(3):622-31. PubMed ID: 22613256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
